Understanding Subutex: A Key Tool in Opioid Addiction Treatment
What is Subutex is a prescription medication with buprenorphine, used for opioid use disorder (OUD). It helps people recover from addiction to heroin or painkillers by reducing cravings and withdrawal symptoms without the “high” of other opioids.
Quick Facts About Subutex:
- Active Ingredient: Buprenorphine (a partial opioid agonist)
- Primary Use: Treatment of opioid dependence
- Form: Sublingual tablets (dissolves under the tongue)
- Key Difference: Contains only buprenorphine (unlike Suboxone, which includes naloxone)
- Brand Status: Discontinued in the U.S. in 2011, but generic versions are available
- How It Works: Reduces cravings, blocks withdrawal symptoms, and prevents euphoria from other opioids
If you or a loved one is struggling with opioid addiction, understanding your treatment options is a vital first step. Subutex is part of medication-assisted treatment (MAT), a proven method combining medication with counseling and behavioral support.
This guide covers everything about Subutex—how it works, side effects, proper use, and how it compares to other treatments. You’ll learn about its risks and how to access help safely.
I am Dr. Chad Elkin, founder of National Addiction Specialists, and I’ve helped thousands of patients understand what is Subutex and its role in their recovery. My goal is to provide clear, honest information so you can make informed health decisions.
What is Subutex and How Does It Work?
When someone asks what is Subutex, they’re really asking about buprenorphine—the active ingredient that makes recovery from opioid addiction possible. Understanding how it works is the first step toward feeling confident about treatment.
Buprenorphine is a partial opioid agonist. Unlike drugs like heroin that fully activate the brain’s opioid receptors, buprenorphine activates them just enough to quiet cravings and ease withdrawal without euphoria. This creates a ceiling effect, meaning that after a certain dose, taking more won’t increase its effects, especially the dangerous slowing of breathing. This built-in safety feature gives buprenorphine a much lower risk of fatal overdose.
Because buprenorphine binds so firmly to opioid receptors, it blocks other opioids from attaching. If someone on buprenorphine treatment tries to use heroin or painkillers, they won’t feel the same high. This blocking action helps protect people from relapse. The Facts about Buprenorphine for Treatment of Opioid Addiction from SAMHSA provides more scientific detail.
The Active Ingredient: Buprenorphine’s Mechanism
Buprenorphine has a high affinity for mu-opioid receptors, meaning it binds to them powerfully and has a slow dissociation rate, staying attached for an extended time. This tight, long-lasting grip allows it to outcompete other opioids, which helps prevent relapse.
The slow release also means buprenorphine works for up to 24 hours, so most people only need one daily dose. If treatment is stopped, withdrawal symptoms are often milder than with full agonists because the medication leaves the system gradually. Legally, buprenorphine is a Schedule III controlled substance, a classification that recognizes its medical value and need for oversight.
What is Subutex used for?
What is Subutex prescribed for? The primary use is treating opioid use disorder (OUD), whether the dependence is on heroin, oxycodone, or other opioids.
Subutex is especially important during the induction phase of medication-assisted treatment (MAT), the first few days of transitioning from other opioids to buprenorphine. This phase requires medical supervision to prevent precipitated withdrawal. While buprenorphine is used for pain management in other forms, Subutex sublingual tablets are designed specifically for opioid dependence.
In some cases, doctors prescribe buprenorphine monotherapy (like generic Subutex) for maintenance treatment. This is common during pregnancy or for patients with a hypersensitivity to naloxone. The goal of MAT is to combine medication with counseling and behavioral support to treat the whole person, which is the key to lasting recovery.
Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.
Learn more about getting started
Subutex: Unique Features and Clinical Considerations
Understanding what is Subutex means knowing what makes it different from other OUD medications. The key distinction is that Subutex contains only buprenorphine, without the naloxone found in combination products like Suboxone.
This “monotherapy” approach has specific uses. The brand name Subutex was discontinued in 2011 as combination products with naloxone (an abuse deterrent) became more common. However, generic buprenorphine monotherapy is still available and plays a vital role in treatment for specific patients. While there’s a higher theoretical risk of misuse without naloxone, its absence makes it the preferred choice in certain clinical scenarios.
Why a Doctor Might Prescribe Subutex
A doctor might prescribe generic buprenorphine monotherapy when a simpler formulation is safer or more effective for a patient.
-
During pregnancy, buprenorphine monotherapy is often preferred. While naloxone is likely safe, many providers choose buprenorphine alone to simplify treatment for the expectant parent. Studies suggest buprenorphine may lead to less severe neonatal abstinence syndrome (NAS) than methadone. For more details, see this advisory on whole person care of pregnant people with OUD.
-
Some individuals have a documented allergy or hypersensitivity to naloxone. For them, a combination product could trigger an allergic reaction, making monotherapy the only safe option.
-
During the supervised induction phase, some providers prefer monotherapy. When a patient first transitions from full opioids, introducing naloxone too soon could cause precipitated withdrawal. In a controlled setting, monotherapy allows for a gentler, more closely monitored transition.
-
Complex medical situations, such as severe liver impairment, might also lead a doctor to choose the simpler medication profile of buprenorphine monotherapy, although this is decided on a case-by-case basis.
At National Addiction Specialists, our providers carefully assess each person’s medical history and treatment goals to determine the safest, most effective medication. We create personalized plans because your recovery journey is unique.
Understanding the Side Effects and Risks of Subutex
Like any medication, what is Subutex (generic buprenorphine) has potential side effects. While it’s a life-saving tool for OUD, knowing what to expect helps you stay safe.
Common side effects are usually mild and often improve as your body adjusts. They include nausea, vomiting, drowsiness, dizziness, headaches, constipation, dry mouth, and increased sweating.
Serious side effects are less common but require immediate medical attention. The most dangerous is respiratory depression (slowed breathing), especially when mixed with other depressants. Other risks include rare liver problems, low cortisol levels (adrenal insufficiency), and serotonin syndrome (a dangerous reaction with certain antidepressants). Allergic reactions (rash, swelling, trouble breathing) and cardiac effects are also possible. Additionally, sublingual buprenorphine has been linked to dental problems like tooth decay, so rinse your mouth with water after the tablet dissolves and see your dentist regularly.
For more information, the FDA provides resources at Information about Medications for Opioid Use Disorder (MOUD).
Addiction, Dependence, and What is Subutex Withdrawal?
It’s important to distinguish between physical dependence and addiction. Physical dependence is a normal physiological response where your body adapts to a medication. Stopping suddenly causes withdrawal. Addiction is a disease involving compulsive drug-seeking despite harmful consequences. You can be dependent on buprenorphine without being addicted to it.
Buprenorphine has a lower abuse potential than full opioids, but misuse can still lead to addiction. If you stop taking it suddenly, you will experience Subutex withdrawal. Symptoms are generally less severe than with full opioids but are still uncomfortable and can include muscle aches, insomnia, anxiety, sweating, runny nose, and stomach cramps. Never stop buprenorphine cold turkey; a medically supervised taper is essential.
Precipitated withdrawal is a sudden, severe withdrawal that occurs if you take buprenorphine too soon after using a full opioid. To avoid this, you must wait until you are in mild-to-moderate withdrawal before your first dose.
Important Precautions and Drug Interactions
Your safety is our priority. The most critical warning is to avoid mixing buprenorphine with other central nervous system (CNS) depressants, as this combination can cause respiratory depression, coma, and death. This includes:
- Alcohol
- Benzodiazepines (Xanax, Klonopin)
- Sedatives, sleep aids, and muscle relaxers
- Other opioids
Tell your doctor about all substances you use. We also monitor liver health, as buprenorphine is processed by the liver. Special considerations are needed for pregnancy and breastfeeding. While treating OUD during pregnancy usually outweighs the risks of Neonatal Opioid Withdrawal Syndrome (NOWS), your baby will need monitoring after birth. The SAMHSA Advisory: Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder – 2023 offers guidance. Buprenorphine passes into breast milk, so infants should be watched for drowsiness.
Many other medications can interact with buprenorphine. Provide your doctor with a complete list of all medications, supplements, and herbal products you take.
How to Use Subutex Safely and Legally
Using what is Subutex correctly involves understanding both medical and legal guidelines. Buprenorphine is a Schedule III controlled substance. A major change in 2022, the Mainstreaming Addiction Treatment (MAT) Act, eliminated the “X-waiver” requirement. Now, any provider with a standard DEA license, like those at National Addiction Specialists, can prescribe buprenorphine for OUD after meeting training requirements. This has greatly improved access to care. You can learn more at DEA Training Requirements.
Proper Administration and Dosage
Take generic Subutex exactly as prescribed. The sublingual tablets must dissolve under your tongue to be effective. If swallowed, the liver breaks down the medication before it can work.
To take your medication: Place the tablet under your tongue and let it dissolve completely (4-8 minutes). Do not chew, crush, or swallow it. Avoid eating, drinking, or talking during this time. After it dissolves, rinse your mouth with water, but wait at least an hour before brushing your teeth to protect your dental health.
Dosage: Your dose depends on your treatment phase. During induction, you must wait until you’re in mild to moderate withdrawal (usually 6-24 hours after your last opioid use) before your first dose to avoid precipitated withdrawal. During the maintenance phase, your dose will be stabilized to control cravings, typically between 8 and 24 mg per day. Never adjust your dose or stop taking Subutex without consulting your doctor.
Safe Storage and Disposal
Safe storage is critical to prevent accidental ingestion, which can be fatal to children or pets. Keep your medication in a secure, locked location. Visit Up and Away for storage tips. Never share or sell your medication; it is illegal and dangerous.
Dispose of unneeded medication properly. The best method is a drug take-back program. If one isn’t available, the FDA provides guidance on which medications can be flushed to prevent misuse. See the FDA’s disposal of unused medicines page for details.
Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.
Hyperlink to https://www.nationaladdictionspecialists.com/new-patient-packet/
Finding Treatment and Starting Your Recovery Journey
Understanding what is Subutex is an important step, but medication alone is not enough for lasting recovery. Buprenorphine provides a stable foundation by reducing cravings, but true healing from OUD requires comprehensive support for your mental and emotional health. This integrated approach combines medication with counseling and behavioral therapy.
At National Addiction Specialists, we are committed to supporting you through every stage of recovery. We offer telemedicine-based treatment in Tennessee and Virginia, combining medications like buprenorphine with counseling. You can access expert, confidential care from home. We accept Medicaid and Medicare because everyone deserves a chance at recovery. Our providers will create a personalized plan that fits your life and goals.
Resources for Help and Support
If you’re ready to take the next step, these resources can help you get started:
- National Addiction Specialists: We offer convenient, confidential telemedicine appointments with experienced providers. Our integrated approach gives you the best chance at long-term success.
- FindTreatment.gov: A federal resource to search for state-licensed treatment providers across the country.
- 988 Suicide & Crisis Lifeline: Connects you with trained counselors 24/7 via call or text.
- Opioid Treatment Program Directory: Helps you find SAMHSA-certified programs for more intensive, in-person care.
Your recovery journey is unique. What matters most is taking the first step. We’re here to support you with compassionate, expert care. Don’t wait—your future is worth it.
This article was medically reviewed by:
Chad Elkin, MD, DFASAM is a board-certified addiction medicine physician, founder, and Chief Medical Officer of National Addiction Specialists, dedicated to treating substance use disorders. A Distinguished Fellow of the American Society of Addiction Medicine (ASAM), Dr Elkin currently serves as President of the Tennessee Society of Addiction Medicine (TNSAM) and has held various leadership roles within the organization. Dr Elkin chairs ASAM’s Health Technology Subcommittee and is an active member of its Practice Management and Regulatory Affairs Committee, State Advocacy and Legislative Affairs Committee, and other committees. He also serves on the planning committee for the Vanderbilt Mid-South Addiction Conference. Committed to advancing evidence-based policy, Dr Elkin is Chairman of the Tennessee Association of Alcohol, Drug, & Other Addiction Services (TAADAS) Addiction Medicine Council, which collaborates with the TN Department of Mental Health & Substance Abuse Services (TDMHSAS). He has contributed to numerous local, state, and national task forces, helping develop professional guidelines, policies, and laws that align with best practices in addiction medicine. His work focuses on reducing addiction-related harm, combating stigma, and ensuring access to effective treatment.Passionate about the field of addiction medicine, he remains dedicated to shaping policy and enhancing patient care.
Suboxone® and Subutex® are a registered trademark of Indivior UK Limited. Any mention and reference of Suboxone® and Subutex® in this website is for informational purposes only and is not an endorsement or sponsorship by Indivior UK Limited.
